Pharmaceutic agent, method of treating psychoses, method of obtaining ziprasidone hydrochloride monohydrate and method of obtaining such pharmaceutic agent

Pharmaceutic agent, method of treating psychoses, method of obtaining ziprasidone hydrochloride monohydrate and method of obtaining such pharmaceutic agent

Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ARENSON DANIEL RAY, BUSCH FRANK ROBERT, RASADI BIJAN, HAUSBERGER ANGELA CAROL GATLIN
Format: Patent
Sprache:eng ; pol
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.